Results 101 to 110 of about 6,049 (169)

Experience with early treatment using febuxostat in a patient with adenine phosphoribosyltransferase deficiency after pediatric kidney transplantation: a case report. [PDF]

CEN Case Rep
Aoki Y, Maeda M, Hashimoto J, Zaitsu A, Ueno K, Furukawa S, Ochiai S, Sakurabayashi K, Yonekura T, Itabashi Y, Muramatsu M, Kawamura T, Hamasaki Y, Sakai K.   +13 more
europepmc   +1 more source

Efficacy and Safety of Ultra-Low Starting Dose Febuxostat Titration in Male Patients With Primary Gout. [PDF]

Int J Rheum Dis
Huizhen S, Yadi L, Lin G, Rui S, Xuemei G, Ping L.   +5 more
europepmc   +1 more source

Comparative Antioxidant Effects of Allopurinol and Febuxostat in Doxorubicin-Treated Rats

Background and objectives: Doxorubicin (DOX) suffers from the limitation of oxidative and nitrosative stress-derived cardiac toxicity during clinical use.
Hani M. Almukhtar, Ali G. Kanaan
core   +1 more source

Cardiovascular Safety of Febuxostat vs. Allopurinol in Gout Patients with Cardiovascular Diseases: A Target Trial Emulation. [PDF]

Clin Pharmacol Ther
Wang X, Cheng X, Wan YW, Wang Y, Ding S, Ying Z.   +5 more
europepmc   +1 more source

Febuxostat attenuates chronic kidney disease induced by adenine in rats: role of TLR4/NF-κB/NLRP3/Caspase1/IL-1β pathway. [PDF]

Inflammopharmacology
Nour OA, Samaha MM, Sewilam HM, El-Kashef DH.   +3 more
europepmc   +1 more source

Differential associations of febuxostat and allopurinol with incident and worsening frailty risk in nephrology patients. [PDF]

Int J Med Sci
Lee SY, Wang J, Yoo KD, Chao CT, Chien KL, Hung KY.   +5 more
europepmc   +1 more source

Interaction of Febuxostat with Human Serum Albumin and Its Application as a Circular Dichroism Probe for Monitoring Albumin Conformational Changes. [PDF]

ACS Omega
Tokuno M, Yokota S, Commey KL, Nishi K, Tsukigawa K, Otagiri M, Yamasaki K.   +6 more
europepmc   +1 more source

Using Pharmacovigilance Data for Signal Detection of Drug Interactions for Rosuvastatin. [PDF]

Basic Clin Pharmacol Toxicol
Levomäki R, Hirvensalo P, Tornio A, Filppula AM.   +3 more
europepmc   +1 more source

Febuxostat alleviates testicular dysfunction induced by cyclophosphamide in rats via modulation of pyroptosis and mTOR autophagy axis. [PDF]

Sci Rep
Atia HA, Elariny HA, Abdallah MH, Khalifa AM, Hellal D, Alghubayshi A, Kabel AM.   +6 more
europepmc   +1 more source

Febuxostat administration for the prevention of tumour lysis syndrome: A meta-analysis

, 2019
What is known and objective: Tumour lysis syndrome is an oncological emergency, characterized by rapid cytolysis leading to an abrupt rise of serum uric acid levels.
Bellos, I., Kontzoglou, K., Pergialiotis, V., Psyrri, A.   +3 more
core